Degarelix (acetate)

Degarelix (acetate)

CAT N°: 24069
Price:

From 176.00 149.60

Degarelix is a synthetic gonadotropin-releasing hormone receptor (GNRHR) antagonist (IC50 = 3 nM in HEK293 cells expressing the human receptor).{39553} It inhibits the growth of WPMY-1, WPE1-NA22, BPH-1, and LNCaP prostate cell lines following a 72-hour incubation at a concentration of 10 ?M via caspase activation and induction of apoptosis.{39554} In vivo, degarelix (2 mg/kg) decreases plasma testosterone levels in rats to castrate levels for the first 49 days post administration.{39553} It decreases tumor volume of Dunning R3327H prostate tumor flank implants in rats when administered at a dose of 1 mg/kg per month.{39555} Formulations containing degarelix have been used in the treatment of advanced prostate cancer.

We also advise you